BCL6 and lymphoma: The World Health Organization (WHO) classification considers cases with concurrent MYC and BCL2 and/or BCL6 rearrangement determined by fluorescence in situ hybridization (FISH) as “double-hit” lymphomas (DHL) or “triple-hit” lymphomas (THL), respectively.